chartexchange

BBC
Virtus Biotech Clinical Trials ETF
stockNYSEETF

Market OpenNov 13, 2026 12:51:17 PM EST
42.62USD+0.234%(+0.10)1,378
41.76Bid42.27Ask0.51Spread
Loading…
Loading…
HQ
USA
Previous Close
$42.53
Beta
1.35
52-Week High
$56.18 2026-08-19
52-Week Low
$32.16 2025-11-17
SMA 50
$44.91
SMA 200
$45.71
Avg. Vol 10D
68,091
Avg. Vol 30D
46,490
Avg. Vol 90D
28,525
Relative Vol
0.03
700,004
700,004
20.4400%
Dec 20, 2017 · $0.297
Oct 6, 2026
BBC Profile

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval. The fund is non-diversified.

BBC Performance
PeriodPriceDateChangeBeta
1W44.992026-11-09-7.58%1.655
1M39.122026-10-16+6.29%1.695
3M53.262026-08-17-21.93%1.572
6M42.442026-05-15-2.03%1.328
1Y32.882025-11-17+26.47%1.351
2Y26.532024-11-15+56.73%—
5Y44.592021-11-16-6.76%1.284
BBC Stock Summary

Virtus Biotech Clinical Trials ETF (NYSE:BBC) stock price today is $41.58, and today's volume is 1,376. BBC is down 2.223% today. The 30 day average volume is 46,490. BBC market cap is $29.11M with 700,004 shares outstanding.